Ohcanbohtosat - David Cuthbertson

Aiddostahte ozu
  1. 1
    Prevalence and Significance of Retinopathy in Subjects With Type 1 Diabetes of Less Than 5 Years’ Duration Screened for the Diabetes Control and Complications Trial

    Prevalence and Significance of Retinopathy in Subjects With Type 1 Diabetes of Less Than 5 Years’ Duration Screened for the Diabetes Control and Complications Trial Dahkki John I. Malone, Anthony Morrison, Peter R. Pavan, David Cuthbertson

    Almmustuhtton 2001
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Long-Term Outcome of Individuals Treated With Oral Insulin

    Long-Term Outcome of Individuals Treated With Oral Insulin Dahkki Kendra Vehik, David Cuthbertson, Holly Ruhlig, Desmond Schatz, Mark Peakman, Jeffrey P. Krischer

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Role of Insulin Resistance in Predicting Progression to Type 1 Diabetes

    Role of Insulin Resistance in Predicting Progression to Type 1 Diabetes Dahkki Ping Xu, David Cuthbertson, Carla J. Greenbaum, Jerry P. Palmer, Jeffrey P. Krischer

    Almmustuhtton 2007
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Characterization of Severity in Zellweger Spectrum Disorder by Clinical Findings: A Scoping Review, Meta-Analysis and Medical Chart Review

    Characterization of Severity in Zellweger Spectrum Disorder by Clinical Findings: A Scoping Review, Meta-Analysis and Medical Chart Review Dahkki Mousumi Bose, Christine Yergeau, Yasmin D’Souza, David Cuthbertson, Melisa J. Lopez, Alyssa Smolen, Nancy Braverman

    Almmustuhtton 2022
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    HOMA-IR and the Matsuda Index as predictors of progression to type 1 diabetes in autoantibody-positive relatives

    HOMA-IR and the Matsuda Index as predictors of progression to type 1 diabetes in autoantibody-positive relatives Dahkki Alessandra Petrelli, Federica Cugnata, Debora Carnovale, Emanuele Bosi, Ingrid Libman, Lorenzo Piemonti, David Cuthbertson, Jay M. Sosenko

    Almmustuhtton 2023
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure

    The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure Dahkki Robert S. Brumberg, Martin R. Back, Paul A. Armstrong, David Cuthbertson, Murray L. Shames, Brad Johnson, Dennis F. Bandyk

    Almmustuhtton 2007
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Glucose and C-Peptide Changes in the Perionset Period of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1

    Glucose and C-Peptide Changes in the Perionset Period of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1 Dahkki Jay M. Sosenko, Jerry P. Palmer, Lisa Rafkin‐Mervis, Jeffrey P. Krischer, David Cuthbertson, Della Matheson, Jay S. Skyler

    Almmustuhtton 2008
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Prognostic Performance of Metabolic Indexes in Predicting Onset of Type 1 Diabetes

    Prognostic Performance of Metabolic Indexes in Predicting Onset of Type 1 Diabetes Dahkki Ping Xu, Yougui Wu, Yiliang Zhu, Getachew Dagne, Giffe T. Johnson, David Cuthbertson, Jeffrey P. Krischer, Jay M. Sosenko, Jay S. Skyler

    Almmustuhtton 2010
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Trends of Earlier and Later Responses of C-peptide to Oral Glucose Challenges With Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 Participants

    Trends of Earlier and Later Responses of C-peptide to Oral Glucose Challenges With Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 Participants Dahkki Jay M. Sosenko, Jerry P. Palmer, Lisa Rafkin, Jeffrey P. Krischer, David Cuthbertson, Carla J. Greenbaum, George S. Eisenbarth, Jay S. Skyler

    Almmustuhtton 2009
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    Incident Dysglycemia and Progression to Type 1 Diabetes Among Participants in the Diabetes Prevention Trial–Type 1

    Incident Dysglycemia and Progression to Type 1 Diabetes Among Participants in the Diabetes Prevention Trial–Type 1 Dahkki Jay M. Sosenko, Jerry P. Palmer, Lisa Rafkin‐Mervis, Jeffrey P. Krischer, David Cuthbertson, Jeffery Mahon, Carla J. Greenbaum, Catherine C. Cowie, Jay S. Skyler

    Almmustuhtton 2009
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    Pancreatic Islet Autoantibodies as Predictors of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1

    Pancreatic Islet Autoantibodies as Predictors of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1 Dahkki Tihamer Orban, Jay M. Sosenko, David Cuthbertson, Jeffrey P. Krischer, Jay S. Skyler, Richard A. Jackson, Liping Yu, Jerry P. Palmer, Desmond Schatz, George S. Eisenbarth

    Almmustuhtton 2009
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    A Risk Score for Type 1 Diabetes Derived From Autoantibody-Positive Participants in the Diabetes Prevention Trial–Type 1

    A Risk Score for Type 1 Diabetes Derived From Autoantibody-Positive Participants in the Diabetes Prevention Trial–Type 1 Dahkki Jay M. Sosenko, Jeffrey P. Krischer, Jerry P. Palmer, Jeffrey L. Mahon, Catherine C. Cowie, Carla J. Greenbaum, David Cuthbertson, John M. Lachin, Jay S. Skyler

    Almmustuhtton 2008
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's)

    An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's) Dahkki Carol A. Langford, Paul A. Monach, Ulrich Specks, Philip Seo, David Cuthbertson, Carol A. McAlear, Steven R. Ytterberg, Gary S. Hoffman, Jeffrey P. Krischer, Peter A. Merkel

    Almmustuhtton 2013
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  14. 14
    Phase I Combination Trial of Lenalidomide and Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes

    Phase I Combination Trial of Lenalidomide and Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes Dahkki Mikkael A. Sekeres, Alan F. List, David Cuthbertson, Ronald Paquette, Rebecca Ganetsky, D Latham, Katarina Paulic, Manuel Afable, Hussain I. Saba, Thomas P. Loughran, Jaroslaw P. Maciejewski

    Almmustuhtton 2010
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  15. 15
    Effects of Oral Insulin in Relatives of Patients With Type 1 Diabetes

    Effects of Oral Insulin in Relatives of Patients With Type 1 Diabetes Dahkki Jay S. Skyler, Jeffrey P. Krischer, Joseph I. Wolfsdorf, Catherine C. Cowie, Jerry P. Palmer, Carla J. Greenbaum, David Cuthbertson, Lisa Rafkin‐Mervis, H. Peter Chase, Ellen W. Leschek

    Almmustuhtton 2005
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  16. 16
    Validation of the Diabetes Prevention Trial–Type 1 Risk Score in the TrialNet Natural History Study

    Validation of the Diabetes Prevention Trial–Type 1 Risk Score in the TrialNet Natural History Study Dahkki Jay M. Sosenko, Jay S. Skyler, Jeffrey L. Mahon, Jeffrey P. Krischer, Craig A. Beam, David Boulware, Carla J. Greenbaum, Lisa Rafkin, Catherine C. Cowie, David Cuthbertson, Jerry P. Palmer

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  17. 17
    Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis

    Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis Dahkki Peter A. Merkel, David Cuthbertson, Bernhard Hellmich, Gary S. Hoffman, David Jayne, Cees G. M. Kallenberg, Jeffrey P. Krischer, Raashid Luqmani, Alfred Mahr, Eric L. Matteson, Ulrich Specks, John H. Stone

    Almmustuhtton 2008
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  18. 18
    Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for Improving the Accuracy of the Risk Classification of Type 1 Diabetes

    Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for Improving the Accuracy of the Risk Classification of Type 1 Diabetes Dahkki Jay M. Sosenko, Jay S. Skyler, Jeffrey L. Mahon, Jeffrey P. Krischer, Carla J. Greenbaum, Lisa Rafkin, Craig A. Beam, David Boulware, Della Matheson, David Cuthbertson, Kevan C. Herold, George S. Eisenbarth, Jerry P. Palmer

    Almmustuhtton 2014
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  19. 19
    New Features of Disease After Diagnosis in 6 Forms of Systemic Vasculitis

    New Features of Disease After Diagnosis in 6 Forms of Systemic Vasculitis Dahkki Peter C. Grayson, David Cuthbertson, Simon Carette, Gary S. Hoffman, Nader Khalidi, Curry L. Koening, Carol A. Langford, Kathleen Maksimowicz‐McKinnon, Paul A. Monach, Philip Seo, Ulrich Specks, Steven R. Ytterberg, Peter A. Merkel

    Almmustuhtton 2013
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  20. 20
    Association of Vascular Physical Examination Findings and Arteriographic Lesions in Large Vessel Vasculitis

    Association of Vascular Physical Examination Findings and Arteriographic Lesions in Large Vessel Vasculitis Dahkki Peter C. Grayson, Gunnar Tómasson, David Cuthbertson, Simon Carette, Gary S. Hoffman, Nader Khalidi, Carol A. Langford, Carol A. McAlear, Paul A. Monach, Philip Seo, Kenneth J. Warrington, Steven R. Ytterberg, Peter A. Merkel

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: